Work Impairment During Alitretinoin Care: The 631-Patient PASSION Study
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured scene is an AI-created illustration of fictional people and work settings, not a patient, diagnosis, before-and-after image or Dr. Arsy #003 result.
The practical question
Work impairment improved among followed patients, but high dropout and the uncontrolled design prevent a causal or universal effectiveness claim.
The study is most useful when its population, design, denominator and timepoint stay attached. A percentage from a clinic, registry, survey or prevention program is not an individual prediction and cannot diagnose the cause of a rash.
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 631 adults with severe chronic hand eczema treated with prescription alitretinoin in routine practice |
| Design | Prospective open-label observational study without an untreated comparator |
| Timepoint | Up to 24 weeks |
| Key result | 279 participants (44.2%) dropped out; among observed follow-up, 29.8% were rated clear or almost clear at week 24, while strong or very strong workplace impairment declined from 49.4%/29.1% to 8.5%/1.4% |
Reading the result carefully
279 participants (44.2%) dropped out; among observed follow-up, 29.8% were rated clear or almost clear at week 24, while strong or very strong workplace impairment declined from 49.4%/29.1% to 8.5%/1.4%.
Treatment selection, regression to the mean, co-care and attrition can influence results. This is prescription-drug evidence and does not transfer to a cosmetic moisturizer.
That distinction matters. A correlation can identify a pattern without proving cause. A before-and-after program can show change without showing which component produced it. A mean can also conceal a smaller group with persistent severe disease, very high cost or prolonged absence.
What this can mean at work
When reading routine-care studies, keep the denominator, dropout and comparator visible before interpreting a dramatic percentage change.
A useful occupational history identifies the exact task, material, frequency, wet-work time, glove type, cleaning method, symptom timing and functional effect. Prevention follows a hierarchy: eliminate or substitute hazards where feasible, control the process, train the worker, and then use correctly selected protective equipment. Moisturizer can support dry-skin comfort; it cannot neutralize a hazardous exposure.
Questions to bring to care
- Which diagnosis and exposure hypothesis best fit the timing and distribution?
- Is clinician-directed patch testing or occupational review appropriate?
- What concrete outcome will be tracked: severity, sleep, function, absence, productivity or job retention?
- What would trigger urgent evaluation, such as rapidly spreading redness, drainage, fever, severe pain or major functional loss?
Primary and authoritative sources
- Primary medical research record: PubMed PMID 27618281
- NIAMS: atopic dermatitis overview
- American Academy of Dermatology: skin-care guidance
- NIOSH: occupational skin-exposure recommendations
PubMed indexing is not NIH endorsement of a study’s interpretation, this article or any product.
Where a cosmetic moisturizer fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003, and external results do not become product results. #003 is not an eczema medicine and this article makes no treatment, cure, prevention, pediatric-safety or 24-hour claim.
Bottom line
The responsible conclusion is the narrow one: preserve the denominator, comparator, timepoint and limitations, then use the study to ask better clinical and workplace questions rather than to promise a universal result.
Educational content only. Researchers and cited organizations do not endorse Dr. Arsy.